Clinical Trial Update: Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating melatonin cream for acute radiation dermatitis in patients with early breast cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Radiation Dermatitis

Drugs mentioned

• melatonin cream (melatonin)

Snippet

Sponsor: Dennis Bregner Zetner | Conditions: Radiation Dermatitis, Radiation Dermatitis Acute | Phase 2 | Status: COMPLETED